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ABSTRAK
Latar belakang: diabetes telah menjadi salah satu masalah kesehatan utama di masyarakat dengan 
perkiraan jumlah 180 juta kasus di seluruh dunia. Pengelolaan nutrisi merupakan salah satu aspek penting 
dalam tatalaksana diabetes melitus tipe 2. Beberapa penelitian telah menunjukkan bahwa terdapat hubungan 
antara diet nabati dan perbaikan kontrol glikemik pada diabetes melitus tipe 2, namun hubungan tersebut masih 
belum dapat disimpulkan. Tujuan artikel ini adalah melakukan penilaian kritis untuk menganalisis apakah diet 
nabati dapat mengurangi kadar HbA1c dibandingkan dengan diet konvensional. Metode: penelusuran literatur 
menggunakan PubMed, Ovid, EBSCO, dan Cochrane Library. Semua abstrak dan judul dari hasil pencarian 
awal disaring dan hasil pencarian akhir ditelaah dengan kritis menggunakan lembar kerja penilaian Center of 
Evidence-Based Medicine, University of Oxford. Hasil: satu tinjauan sistematis dan dua uji klinis memenuhi 
kriteria inklusi dan dianggap memenuhi syarat untuk diikutsertakan dalam laporan kasus ini. Pada pasien 
dengan diabetes melitus tipe 2, HbA1c secara signifikan mengalami penurunan lebih besar pada kelompok diet 
nabati dibandingkan dengan kelompok diet konvensional setelah 22 minggu. Selain itu, terdapat penurunan 
yang lebih besar secara signifikan terhadap kadar HbA1c pada kelompok dengan diet nabati setelah 72 minggu. 
Berdasarkan hasil yang diperoleh, konsumsi diet nabati memiliki hubungan yang signifikan terhadap penurunan 
HbA1c. Kesimpulan: pada pasien dengan diabetes melitus tipe 2, penurunan kadar HbA1c lebih tinggi pada 
pasien dengan diet nabati dibandingkan dengan pasien dengan diet konvensional. Untuk penelitian selanjutnya 
sebaiknya dilakukan dengan menggunakan jumlah sampel yang lebih besar dan waktu tindak lanjut yang lebih 
panjang.
Kata kunci: tipe 2 diabetes melitus, diet, vegan, vegetarian, glukosa, HbA1c.
ABSTRACT
Background: diabetes has become a major public health concern with an estimated 180 million cases 
worldwide. Nutritional adjustment is one of the key aspects in the management of type 2 diabetes mellitus. 
Previous studies have suggested an association between vegetarian diets and improvements in glycemic control 
in type 2 diabetes mellitus, however the relationship is not well established. The aim of this report is to perform 
a critical appraisal to analyze whether plant-based diet reduces the HbA1c level compared to conventional diet. 
Methods: a comprehensive computer-based literature search was performed on June 20, 2016 using PubMed, 
Ovid, EBSCO, and the Cochrane Library. All abstracts and titles from the initial search results were screened, 
reviewed, and appraised using critical appraisal worksheets by Center of Evidence-Based Medicine, University 
of Oxford. Results: one systematic review and two RCTs met the inclusion criteria and were considered eligible 
for this case report. In patients with type 2 diabetes mellitus, HbA1c significantly yielded greater reduction in 
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the plant-based group compared to conventional diet group after 22 weeks of follow up. Similarly, there was a 
statistically greater reduction in HbA1c level in the plant-based group after 72 weeks. Furthermore, consumption 
of plant-based diet was associated with a significant reduction in HbA1c. Conclusion: in patients with type 
2 diabetes mellitus, HbA1c reduction was greater in patients with plant-based diet compared to patients with 
conventional diet. Further research should be conducted with larger sample size and longer follow-up period. 
Keywords: diabetes mellitus, type 2, diet, vegans, glucose, HbA1c.
INTRODUCTION
Diabetes has become a major public health 
concern with an estimated 180 million cases 
worldwide.1 The number of people worldwide 
with type 2 diabetes mellitus is expected to double 
by 2030.2 In Indonesia, based on the data from 
RISKESDAS 2013 (Riset Kesehatan Dasar), it 
was estimated that the proportion of Indonesian 
population ≥15 years of age with type 2 diabetes 
mellitus is 6.9%.3 Based on the data by IDF 
(International Diabetes Federation) in 2014, 
Indonesia ranked fifth among countries with the 
highest proportion of type 2 diabetes mellitus. This 
is a setback compared to the 2013 data, in which 
Indonesia was placed on the seventh position. The 
problem in Indonesia is that not all patients are 
able to get adequate access to healthcare. There 
is also lack of availability of oral hypoglycemic 
drugs in primary healthcare center (Puskesmas) 
as well as other healthcare centers. In addition, 
there is lack of ability among healthcare providers 
in managing diabetes cases, specifically in 
preventive, curative, and rehabilitative aspects.4
Nutritional adjustment is one of the key 
aspects in the management of type 2 diabetes 
mellitus. The main principle of nutritional 
management of type 2 diabetes is hypocaloric 
diet, which is low in calories.5 The dietary 
approaches for managing type 2 diabetes include 
limiting carbohydrate intake, limiting intake 
of saturated and trans fats and cholesterol, and 
reducing energy intake in overweight individuals. 
However, one of the major problems with 
conventional hypocaloric diet is poor long-term 
patient adherence. Alternatively, vegetarian or 
plant-based diet may be a convenient strategy to 
encourage consumption of foods with a lower 
energy density.6
Vegetarian diets are characterized by 
elimination of all flesh foods from the diet and 
typically based on the consumption of whole 
grains, legumes, vegetables, fruits, and nuts, 
while still consuming eggs and dairy products 
like milk and butter. On the other hand, the 
term vegan refers to diets contain only plant 
foods. In randomized trials, vegetarian and 
low-fat vegan diets have been shown to improve 
glycemic control, blood lipid concentrations, and 
body weight compared to conventional dietary 
guideline, which includes the consumption 
of animal products.6 These improvements 
may be due to the fact that individuals who 
adhere to plant-based eating pattern typically 
consume fewer calories and less fat, saturated 
fat, and cholesterol and consume more fiber, 
potassium, and vitamin C. Recently, both the 
American Academy of Nutrition and Dietetics 
and the American Diabetes Association (ADA) 
included well-planned, plant-based eating 
patterns (vegetarian and vegan) as a nutritional 
intervention in their recommendations for people 
with diabetes.7
Previous studies have found that plant-based 
eating patterns combined with exercise have been 
found to improve diabetes control and reduce 
the need for medication. Specifically, several 
studies have suggested an association between 
vegetarian diets and improvements in glycemic 
control in type 2 diabetes mellitus, however the 
relationship is not well established.7 As a result, 
it is timely to advise an effective dietary plan to 
contribute to an overall management plan for 
patients with type 2 diabetes mellitus, especially 
for those who are unable to afford flesh foods in 
their daily dietary regiment.
CLINICAL QUESTION
A 51-year-old female came to the clinic for 
routine control for type 2 diabetes mellitus. She 
was diagnosed with type 2 diabetes mellitus 
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since 1 year ago. Patient was worried because 
her blood glucose levels were still high. She 
also complained of pain and tingling sensations 
on her both feet since 1 month ago. Due to 
this complaint, patient was unable to work, 
therefore she could not help her husband as the 
breadwinner in the family. 
Patient was diagnosed with type 2 diabetes 
mellitus in 2015 when she went to the clinic with 
the chief complaint of fatigue. In addition, patient 
also complained of excessive thirst, excessive 
hunger, and nocturnal urination. Laboratory 
examinations for her glucose level were 
conducted and the result showed that her random 
blood glucose level was approximately 500 and 
she was asked to return to the clinic the next 
morning to check for her fasting blood glucose 
and post prandial glucose. The tests showed 
that the patient’s fasting blood glucose was 271, 
while the postprandial glucose was 441. Patient 
was given two oral hypoglycemic agents which 
are Metformin and Glibenclamid and she was 
asked to come to the clinic the following month 
for routine control. However, patient used to skip 
her routine control schedule and there was a time 
when she did not consume oral hypoglycemic 
drugs. Upon physical examination, vital signs 
were within normal limits. Examination of 
eyes, lungs, cardiovascular, and abdomen were 
also within normal limits. However, the touch 
sensitivity test revealed that there was loss of 
sensitivity on the plantar side of both feet.
The latest blood glucose measurements of this 
patient was 243 mg/dl for fasting blood glucose 
and 506 mg/dl for postprandial. Patient’s HbA1c 
level was 8.2%, which is above the target for 
patients with diabetes mellitus. Patient was given 
three oral hypoglycemic agents, with the addition 
of Acarbose into the regiment. In addition 
medications, patient was also advised to do 
physical activity and diet modifications. Patient 
came from low socio-economic background 
and was unable to afford buying flesh foods for 
protein such as meat and chicken on a regular 
basis. Patient usually ate plant-based foods 
such as white rice with vegetables, tofu (tahu), 
tempeh, crackers, and sometimes alternated with 
eggs or fish.
The clinical question for this EBCR is: “In 
patients with type 2 diabetes mellitus, does plant-
based diet reduce the HbA1c level compared to 
conventional diet?”
METHODS
In order to answer the clinical question, a 
comprehensive computer-based literature search 
was performed on June 20, 2016 using PubMed, 
Ovid, EBSCO, and the Cochrane Library. 
The searching process used combinations 
of Boolean operators such as ‘AND’ and 
‘OR’ and the following key words: ‘plant-
based’, ‘vegetarian’, ‘vegan’, ‘diet’, ‘diabetes’, 
‘HbA1c’, and ‘glucose’. Limits placed on the 
search included ‘English’, ‘humans’, ‘full text 
available’, ‘clinical trial’, ’review’, and ‘articles 
published in the last ten years (June 2006 – June 
2016)’. Several searches were conducted in 
order to ensure that all the relevant trials were 
identified. All abstracts and title from the initial 
search results were screened and reviewed in 
order to confirm that they fulfilled the inclusion 
and exclusion criteria. All relevant studies were 
appraised using critical appraisal worksheets by 
Center of Evidence-Based Medicine, University 
of Oxford. 
RESULTS
A total of twelve studies were retrieved 
after the abstract and title screening process in a 
comprehensive computer-based literature search 
(Figure 1). After reading the full-text version 
of the studies, four articles were removed due 
to the irrelevance to the topic. In total, there are 
three articles used in this case report. All of the 
studies were appraised using the criteria from 
Centre of Evidence-Based Medicine University 
of Oxford for randomized clinical trial (RCT) 
and systematic review. (Table 1)
The study by Barnard et al.8 investigated 
whether a low-fat vegan diet improves glycemic 
control and cardiovascular risk factors in 
individuals with type 2 diabetes. Individuals with 
type 2 diabetes were randomly assigned to a low-
fat vegan diet or a diet following the American 
Diabetes Association (ADA) guidelines and 
evaluated at the start of the trial and at 22 weeks. 
The vegan diet consisted of vegetables, fruits, 
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grains, and legumes and participants were asked 
to avoid animal products while the control group 
was assigned to the ADA diet. The outcomes 
assessed in this study include anthropometric 
and glycemic variables, renal variables, and 
lipid profiles. Glycemic variables include HbA1c 
which is measured in percentage (%), fasting 
plasma glucose, measured in mmol/l, and fasting 
plasma glucose , measured in mg/dl.
In all participants, HbA1c fell 0.96 
percentage points (p=0.0001) in the vegan 
group and 0.56 percentage points (p=0.0009) in 
the ADA group. In participants whose diabetes 
medications remained unchanged throughout 
the trial (24 participants in the vegan group and 
33 participants in the ADA group, HbA1c fell 
1.23 points in the vegan group and 0.38 points 
in the ADA group and this result is statistically 
significant (p=0.01; baseline-adjusted p=0.007). 
As for the fasting blood glucose in mmol/l, the 
mean blood glucose level decreased by 1.97 
mmol/l in the vegan group and 1.92 mmol/l in 
the ADA group. However, these results are not 
statistically significant (p=0.92). A similar trend 
was also observed in the fasting blood glucose in 
mg/dl, in which the mean decrease was higher in 
the vegan group with 35.5 mg/dl compared to the 
ADA group 34.6 mg/dl. However, these results 
were not statistically significant (p=0.92). Based 
on the results of glycemic markers and lipid 
profiles, it was shown that both a low-fat vegan 
diet and a diet based on ADA guidelines showed 
improvement, however the improvements were 
greater with a low-fat vegan diet.
The second study was conducted by the same 
principal authors, Barnard et al.9. However this 
study was conducted three years after the first 
study with a longer follow-up period, which 
was up to 74 weeks. Similar with the previous 
study, this study also compared the effects of a 
low-fat vegan diet and conventional diabetes diet 
on glycemic markers, weight, and plasma lipids. 
The study design was also similar, in which 
individuals with type 2 diabetes were randomly 
Figure 1. Flowchart of the searching and selection strategy
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assigned to a low-fat vegan diet or a diet 
following 2003 American Diabetes Association 
guidelines or conventional diet for 74 weeks.
The glycemic markers analyzed in this 
study are HbA1c and fasting plasma glucose 
in mg/dl. For HbA1c, the repeated-measures 
analysis of variance showed significant effects 
for time (p<0.0001) and for diet group-by-time 
interaction (p=0.03). In an intention-to-treat 
analysis which includes all participants, HbA1c 
changes from baseline to 74 week or to the last 
available value were -0.34 for the vegan group 
and - 0.14 for the conventional diet group, 
however this result is not statistically significant 
(P=0.43). The decrease in mean fasting plasma 
glucose was also higher in the vegan group (19.5 
mg/dl) compared to the ADA group (14.0 mg/dl), 
however this result is not statistically significant 
(P=0.61). Similar with the previous study, this 
study also concludes that, a low-fat vegan diet 
appeared to improve glycemia and plasma lipids 
more than conventional diabetes diet.
The third study is a systematic review 
and meta-analysis by Yokoyama et al.10 which 
emphasizes on the associations between 
vegetarian diets and glycemic control in type 
2 diabetes. The studies included in this review 
are clinical trials in adults in which vegetarian 
diets (defined as those excluding meat, poultry, 
and fish) or vegan diets (defined as excluding 
animal-derived food products) were used as 
interventions for at least 4 weeks and changes in 
HbA1c and/ or fasting blood glucose levels were 
reported. The main measure of interest was the 
HbA1c level in patients consuming vegetarian 
or vegan diets, compared with levels in patients 
in the control group (omnivorous diet), while 
the secondary endpoint was the change in the 
fasting blood glucose level. A comprehensive 
literature search was conducted in PubMed, Web 
of Science, EMBASE, and the Cochrane Central 
Register of Controlled Trials. In total, there were 
six studies included in this review. 
The result of this review revealed that 
consumption of vegetarian diets was associated 
with a significant reduction in HbA1c [−0.39 
percentage point; 95% confidence interval 
(CI), −0.62 to −0.15; P=0.001; I2=3.0; P for 
heterogeneity =0.389]. On the other hand, there 
was a non-significant reduction in fasting blood 
glucose concentration (−0.36 mmol/L; 95% CI, 
−1.04 to 0.32; P=0.301; I2=0; P for heterogeneity 
=0.710), compared with consumption of 
omnivorous diet.
DISCUSSION
Prior research has demonstrated that a low-
fat, plant-based nutritional approach improves 
control of weight, glycemia, and cardiovascular 
risk in type 2 diabetes patients.11 In addition, 
studies have reported a dramatic decrease in 
medication use when following a plant-based 
diet. These results are in accordance with studies 
included in this case report in which HbA1c as 
the glycemic marker shows a greater decrease in 
the vegan group compared to the ADA group. In 
addition, the study by Barnard et al.8 also found 
that more patients in the vegan group (43% 
percent or 21 of 49) reduced diabetes medications 
compared to the ADA group (26% or 13 of 50). 
This is due to the fact that a low-fat plant-based 
diet plays an important role in nutrient intake and 
body composition in several ways that may affect 
insulin sensitivity. The underlying mechanism is 
that those types of diets are low in fat and high 
in fiber, therefore typically cause associated 
reductions in dietary energy density and energy 
intake, which are not fully compensated for 
by increased food intake. In addition, weight-
reducing effect of the vegan diet is found to be 
responsible for a significant portion of its effect 
on HbA1c.6
The second study by Barnard et al.9 has 
longer follow up-period compared to the first 
study from the same author. It was shown that the 
result was also the same after long- term follow 
up (74 weeks), in which there was a significantly 
greater decrease in HbA1c changes from baseline 
to week 74 in vegan diet group. However, among 
participants in the vegan group with no changes 
to diabetes medications, HbA1c had fallen 1.23 
by 22 week (n=24) and 0.82 by 74 week (n=14), 
meaning that the decrease was greater in week 22 
compared to week 74. Among the conventional 
diet group, the similar trend was also observed, in 
which HbA1c reduction was greater at week 22 
compared to week 74 (0.38 with n=33 and 0.21 
with n=21, respectively). These results are in 
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accordance to the previous study which implied 
that long-term effect of both diet interventions 
on glycemia was reduced in comparison with the 
short-term findings from this study.8 However, in 
both studies by Barnard et al.9, participants were 
not blinded to the intervention due to the obvious 
differences between the diets, thus making 
the results prone to bias. In addition, most 
participants in both groups altered medications 
due to low blood glucose values, therefore 
presenting a confounding variable that required 
special analyses.
The systematic review by Yokoyama et 
al.10 also found that consumption of vegetarian 
diets was associated with a significant reduction 
in HbA1c. The meta-analysis revealed that a 
vegetarian dietary pattern significantly reduced 
HbA1c by 0.4 percentage point in patients with 
type 2 diabetes. The magnitude of the effect size 
is roughly one-half of that seen with metformin, 
which is used as first-line oral therapy for 
elevated HbA1c levels. On the other hand, the 
reductions seen in fasting blood glucose level 
did not reach statistical significance. One of 
the strengths of this review is that there was no 
significant heterogeneity among the controlled 
trials included in the analysis. However, several 
drawbacks of this review are the fact that trials 
included in this review have small sample sizes 
and some of the studies included in the review 
were not randomized.
Based on the study by Selvin et al.12 this issue 
may be caused by the fact that glucose levels 
are often variable while baseline HbA1c level 
is a stronger predictor of subsequent diabetes 
and cardiovascular events than fasting glucose. 
Moreover, in clinical practice, HbA1c is widely 
used in diabetes care as a reliable marker of 
long- term glycemic control.13 However, since 
HbA1c refers to glycosylated hemoglobin, 
which is developed when glucose attaches to 
the hemoglobin in the red blood cell, HbA1c is 
unable to be used for evaluation purpose in certain 
cases such as anemia, hemoglobinopathy, history 
of blood transfusion within 2-3 months, and 
other conditions which may affect erythrocyte 
life cycle and kidney function.4
In this case, the level of HbA1c of the 
patient is 8.2%, which is still above the target 
for type 2 diabetes mellitus control. Based on 
the meta-analysis, the vegetarian dietary pattern 
only reduced HbA1c level by 0.4 percentage 
point.10 On the other hand, the target HbA1c 
level as written in the criteria for type 2 diabetes 
mellitus control is below 7%. As a result, it is still 
inadequate to rely solely on the diet to decrease 
the HbA1c level to reach the controlled level 
as the management of type 2 diabetes mellitus. 
The patient requires aggressive treatment in 
the form of oral antidiabetic agents (OAD) 
to achieve glycemic and cardiovascular risk 
factor goals. According to the meta-analysis 
by Sherifall et al.,14 the benefit of initiating an 
OAD agent can be seen within the first 4 to 6 
months of administration, with HbA1c levels 
reduction by up to 1.5% on average. Therefore, 
the administration of OAD agent and plant-based 
dietary pattern should be applied simultaneously 
to achieve the desired HbA1c level.
CONCLUSION
Based on the results and discussion of the 
included studies, it is concluded that in patients 
with type 2 diabetes mellitus, HbA1c reduction 
was greater in patients with plant-based diet 
compared to patients with conventional diet.
In patients with type 2 diabetes mellitus, 
fasting blood glucose reduction was greater 
in patients with plant-based diet compared to 
patients with conventional diet.
Further research with larger sample size 
and extensive follow-up period is needed to 
establish a firm conclusion regarding this 
issue. In addition, further studies are needed to 
investigate the relationships between specific 
foods, preferably foods which are commonly 
consumed in the society, and glycemic control. 
In clinical settings, fasting blood glucose is 
more commonly used for glycemic control due 
to its availability and practicality. Based on the 
recent consensus by PERKENI, HbA1c should 
be examined every 3 months or each month 
for cases with high level of HbA1c (>10%). 
Moreover, HbA1c is an excellent marker for 
long-term monitoring for type 2 diabetes mellitus. 
However, because of the lack of availability and 
practicality of HbA1c examination, further 
research with fasting blood glucose as the 
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main outcome should be conducted due to the 
relevance with the clinical settings.
In terms of clinical implementation in this 
patient, along with medications and other lifestyle 
modifications such as exercise, the patient should 
be advised to continue her dietary pattern that 
includes plant-based foods which are rich in 
vegetables, fruits, grains, and legumes. However, 
the patient should be educated in regards to 
the portion size in order to ensure that patient 
gets adequate energy intake and micronutrient, 
especially for sources of vitamin B-12, vitamin 
D, and calcium.
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